Cassava Sciences
SAVA
#8817
Rank
A$0.23 B
Marketcap
A$4.80
Share price
-3.92%
Change (1 day)
1.23%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.22 Billion a decrease over its 2023 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-18.26%
2024 -A$0.22 Billion34.28%
2023 -A$0.16 Billion32.41%
2022 -A$0.13 Billion143.46%
2021 -A$49.49 Million383.92%
2020 -A$10.23 Million36.96%
2019 -A$7.47 Million-25.56%
2018 -A$10.03 Million-44.25%
2017 -A$17.99 Million-20.11%
2016 -A$22.52 Million5.32%
2015 -A$21.39 Million14.23%
2014 -A$18.72 Million-139.64%
2013 A$47.22 M
2010 -A$20.63 Million102.87%
2009 -A$10.17 Million-177.52%
2008 A$13.11 M-14.32%
2007 A$15.3 M-1942.21%
2006 -A$0.84 Million
2004 -A$58.66 Million75.1%
2003 -A$33.5 Million
2001 -A$26.07 Million20.49%
2000 -A$21.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.23 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA